Federal award (BPA CALL, fiscal year 2023)
Recipient: BRILLIENT CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-26 to 2025-01-31
Current total value of award: $518110.16
Description: SERVICES TO PROVIDE REGULATORY SUPPORT FOR GENERIC DRUG PROGRAM ABBREVIATED NEW DRUG APPLICATIONS